CD20 x CD3 Bispecific Antibodies in Non-Hodgkin Lymphoma Management

This chapter discusses the role of CD20 x CD3 bispecific antibodies in the management of Non-Hodgkin Lymphoma, including education and support provided by companies, guidelines developed by the Lymphoma Research Foundation, sequencing of therapy for FL, measuring CD20 expression, and potential cytokine release syndrome.